Antibody Therapeutics for Life

Notices


No Title Written by Written date Inquire
82   PharmAbcine Present Preclinical Data of Blood Vessel Stabilizing PMC-403 at 2020 AACR E-poster   PharmAbcine   2020-06-22   724  
81   PharmAbcine, AACR Annual Meeting 2020 Online Planner   PharmAbcine   2020-06-17   3,458  
80   PharmAbcine execute an agreement with Thermo Fisher for the development and manufacturing of its next-generation immune checkpoint blockade, PMC-309 for Phase I   PharmAbcine   2020-06-12   1,385  
79   PharmAbcine signs a license agreement with Wincal Biopharm to expand indications of PharmAbcine's existing assets to non-oncology areas   PharmAbcine   2020-06-04   282  
78   PharmAbcine to Participate in BIO Digital Conference   PharmAbcine   2020-05-28   4,655  
77   [ Re-announcement], AACR Annual Meeting 2020 Cancelled and Rescheduled for Later This Year   PharmAbcine   2020-03-23   772  
76   PharmAbcine, AACR Annual Meeting 2020   PharmAbcine   2020-03-20   3,614  
75   PharmAbcine, invited speaker at KSMO 2020   PharmAbcine   2020-02-11   1,766  
74   PharmAbcine, to Participate in Both J.P. Morgan Health Conference 2020 and Biotech Showcase in San Francisco, Ca, USA   PharmAbcine   2020-01-08   6,807  
73   PharmAbcine, to Present in KABSP-SF 2020, San Francisco   PharmAbcine   2020-01-03   5,143